MS
EXAS

Maven Securities’s Exact Sciences EXAS Stock Holding History

Maven Securities’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-93,701
Closed -$9.52M – 458
2025
Q4 		$9.52M Buy
+93,701
New +$7.52M 0.21% 116
2019
Q4 		– Sell
-21,000
Closed -$1.9M – 377
2019
Q3 		$1.9M Buy
+21,000
New +$2.39M 0.6% 43

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Maven Securities's EXAS Position: Q1 2026 in Review

Maven Securities sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 93,701 shares — an estimated $9.52M sold.

Maven Securities first reported a position in EXAS in Q3 2019 and held it in 2 quarters. The position peaked at $9.52M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Maven Securities reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Maven Securities sold 93,701 Exact Sciences shares in Q1 2026, an estimated $9.52M.
  • Maven Securities first reported a position in Exact Sciences in Q3 2019 and held it in 2 quarters.
  • Maven Securities's Exact Sciences position peaked at $9.52M in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Maven Securities's 13F filing for Q1 2026, filed 15 May 2026.